Notice of Funding Opportunity for Biomarker Validation in Neurological and Neuromuscular Disorders
National Institutes of Health
Description
This grant supports projects focused on identifying unmet needs for biomarkers and their measurement methods, specifying one or two specific uses for the biomarkers. Applicants can work on optimizing the accuracy, precision, reportable range, and analytical sensitivity and specificity of detection methods across different sites and operators. It also involves establishing reference intervals and quality control procedures. While multi-site projects are encouraged, they are not mandatory.
Applicants must justify the unmet need for the biomarker(s) and measurement methods and specify one or two context(s) of use for the biomarker(s). Activities supported include optimizing and evaluating the accuracy, precision, reportable range, and analytical sensitivity and specificity of the d…
Source
Grant ID
PAR-24-098
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Neurological Disorders and Stroke
Program
SBIR
Key Dates
Opportunity Released
January 22, 2024
Open for Submission
January 22, 2024
Submission Deadline
June 25, 2026
Application Window Closes
June 25, 2026
Eligibility
The following categories of applicants are invited to apply:
- U.S. Small Business Concerns (SBCs) organized for profit with a place of business in the United States (≤500 employees including affiliates) meeting SBA SBIR/STTR definitions
- U.S. SBCs majority-owned and controlled (>50%) by U.S. citizens or permanent residents, or by other qualifying SBCs majority-owned/controlled by such individuals
- U.S. SBCs majority-owned by Indian Tribes, Alaska Native Corporations (ANCs), or Native Hawaiian Organizations (NHOs), or wholly owned entities of such (SBIR/STTR)
- U.S. SBCs majority-owned by multiple venture capital operating companies (VCOCs), hedge funds, or private equity firms (SBIR only; subject to SBA conditions – no single firm >50% unless itself qualifies as an SBC owned/controlled by U.S. individuals)
- Joint ventures that qualify as U.S. SBCs, in which each entity meets SBIR/STTR ownership requirements; JV must have <50% participation by foreign business entities
Similar opportunities
- Clinical Validation of Biomarkers for Neurological and Neuromuscular Disorders
National Institutes of Health
- Funding Opportunity Purpose
National Institutes of Health
- Notice of Funding Opportunity Purpose
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Validation of Biomarkers for Cancer Detection and Treatment
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Biomarker Development
National Institutes of Health